Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH transition notice appears above the unchanged 403 Forbidden page, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:16:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The 403 Forbidden page’s footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:14:44.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the study details with a simple error message and a Home link.
    Difference
    17%
    Check dated 2026-09-22T22:20:34.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, representing a version update of the page. This change does not alter the study details or content presented on the page.
    Difference
    0.1%
    Check dated 2026-09-15T20:52:51.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The Revision label in the page footer was updated from v3.6.5 to v3.6.6, indicating a new version of the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-09-01T18:03:39.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.6.4 to v3.6.5, signaling a minor update to the page template or content without changing the study data.
    Difference
    0.1%
    Check dated 2026-08-11T19:28:11.000Z thumbnail image

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.